InUnio

is a digital platform for standart software solutions and cooperation between science and manufacturers in health
InUnio is a digital platform for standart software solutions and cooperation between science and manufacturers in health

Our mission

We focus on the availability of advanced technologies for the treatment of autoimmune, oncological, cardiac and infectious diseases through the widespread use of personalized approaches.

Personalized medicine is a new unicorn that requires broad cooperation and efficient application of resources based on standard solutions, allowing innovative companies to focus on R&D, avoiding the cost of patchwork automation of standard operations. The availability of standard solutions, professionals and computing power will create momentum for the rapid development of advanced technology companies.

InUnio creates a favorable environment for the development of innovative medical, pharmaceutical and biotechnology companies.

InUnio. О нас
1
2
3
4
5
6
7
1
From accumulated data to idea

Data is always at the heart of the idea generation process. InUnio allows you to get access to data that will enable a continuous flow of idea generation in various fields.

From idea to proven hypothesis

Only 10% of ideas get tested. A data-tested hypothesis allows more resources to be mobilized for implementation.

From proven hypothesis to innovation

Not every tested hypothesis is economically viable for implementation at a given time.

From innovation to clinically proven results

Clinically Proven Treatment complies with domestic and international standards and will attract more audience (doctors and patients).

From Clinically Proven to Scaled Solution

For the implementation of treatment "on stream" it is necessary to develop and implement a significant resource base.

From Scaled Solution to Mass Treatment

Having a clinically proven treatment and a resource base that allows for this treatment, it is possible to move on to the introduction of this treatment in private and public clinics, including with the involvement of insurance companies for inclusion in compulsory medical insurance / VHI.

From Mass Treatment to Big Accumulated Data

Global treatment allows you to accumulate more data, which in the future will allow you to start this cycle anew.

From accumulated data to idea

Data is always at the heart of the idea generation process. InUnio allows you to get access to data that will enable a continuous flow of idea generation in various fields.

From idea to proven hypothesis

Only 10% of ideas get tested. A data-tested hypothesis allows more resources to be mobilized for implementation.

From proven hypothesis to innovation

Not every tested hypothesis is economically viable for implementation at a given time.

From innovation to clinically proven results

Clinically Proven Treatment complies with domestic and international standards and will attract more audience (doctors and patients).

From Clinically Proven to Scaled Solution

For the implementation of treatment "on stream" it is necessary to develop and implement a significant resource base.

From Scaled Solution to Mass Treatment

Having a clinically proven treatment and a resource base that allows for this treatment, it is possible to move on to the introduction of this treatment in private and public clinics, including with the involvement of insurance companies for inclusion in compulsory medical insurance / VHI.

From Mass Treatment to Big Accumulated Data

ПGlobal treatment allows you to accumulate more data, which in the future will allow you to start this cycle anew.

Main elements of the platform

InUnio. Counterparty interaction system
Counterparty interaction system

System combines resource aggregators (sequencing, mass spectrometry, chromatography, peptide synthesis, etc.), bioinformaticians, IT companies, modern research centers and vivariums, research organizations, pharmaceutical and biotech start-ups for efficient work with other counterparties for long-term operations and integrated logistics.

InUnio. Library of white-label IT solutions
Library of white-label IT solutions

Contains ready-made software modules for analysis of omics data, biobanking, data processing from equipment, interpretation of the application of reagents, management of bioinformatics protocols, research management and laboratory operations, quality control, integration of data from various sources (open databases, data from equipment, third party ICs).

InUnio. Data brokerage
Data brokerage

A library of components and drivers for interacting with heterogeneous databases and equipment.

Areas of use

InUnio. Creation of mechanisms for storage and analysis of medical data (biobanks)
Creation of mechanisms for storage and analysis of medical data (biobanks)

What is it: systems for storing and analyzing big medical data, including omics data and phenotypic data from medical information systems, medical images, etc.

Existing solutions: The Cancer Genome Atlas, DNANexus, Seven Bridges.









InUnio. Production of non-antigenic vaccines
Production of non-antigenic vaccines

What it is: Production of vaccines that affect pre-selected cells.

Specialists: surgery, histology, bioinformatics, sequencing equipment, mass spectrometry, peptide synthesis.

Key factors: the quality of the neoantigen evaluation algorithm, the purity of the obtained peptides (for peptide vaccines), the production rate.

Facts: Neoantigen vaccines in combination with various adjuvants have shown a significant improvement in the prognosis for diseases such as melanoma, glioblastoma, breast cancer and several others. https://pubmed.ncbi.nlm.nih.gov/35214655/

Existing solutions: SAP Ariba, IQVIA, Boston Gene, Insilco Medicine.


InUnio. Tumor profiling and liquid biopsy
Tumor profiling and liquid biopsy

What it is: The process of profiling tumors in various implementations involves the collection of genomic material, processing and interpretation of the results based on information from a variety of databases with a heterogeneous structure and degree of completeness.

Specialists in the fields of: surgery, histology, sequencing, logistics, bioinformatics, access to high-quality reagents and sequencing equipment.











InUnio. Typical software for Smart reagents
Typical software for "Smart reagents"

What it is: Production of turnkey laboratory analyzes will reduce the cost of analysis, which will open up the personalized medicine market for a large number of users and improve the quality of treatment by selecting drugs based on individual characteristics.

Key success factors: High-quality reagents, user-friendly software, high-performance algorithms.

Existing solutions: Roche, Agilent, Shimadzu, GE, Waters.

InUnio. Identification of the causes of multifactorial cardiovascular diseases
Identification of the causes of multifactorial cardiovascular diseases

What it is: A quick search for information about the causal relationships of gene variants and their combinations with the conditions of patients, modes of inheritance to assess the risks of diseases.

Topics include the creation of extensible diagnostic panels to detect genomic, transcriptomic or proteomic disorders associated with diseases such as coronary heart disease, strokes, atherosclerosis, long QT syndrome, hypertension and cardiomyopathy of various types, the creation of result interpretation environments using a variety of public databases and articles.


InUnio. Immunological profiling and pharmacogenomics
Immunological profiling and pharmacogenomics

What it is: Creation of immunological profiles of patients to determine the exact dosage and selection of drugs, taking into account genetic characteristics.

Specialists: medicine, chemistry, bioinformatics, molecular biology, use of cell sorting equipment, sequencing, as well as software for data integration and presentation of results.

InUnio. Domestic standard solutions for laboratory data management and clinical research data processing
Domestic standard solutions for laboratory data management and clinical research data processing

What it is: InUnio allows you to save, manage and process laboratory and clinical data in accordance with the requirements of Russian legislation.

Key success factors - import substitution of foreign software.

Facts: The volume of expenses for the acquisition of licenses in 2019-2021 amounted to 2.5 billion rubles. In view of the active import substitution, InUnio acts as an analogue of this software.

Existing import solutions: Waters Empower, Mettler Toledo, Testo, Bruker, BIO-RAD, Sartorius, Labware, Agilent, Veeva, Medidata, Open Clinic.






How it works?

InUnio. Conducting a new study
Conducting a new study
  1. Formation of hypotheses using already accumulated data.
  2. Conducting research using existing service providers, including the search and selection of candidates for research.
  3. Conducting clinical trials and creating publications + informing users of the platform about research.
  4. Conducting protocol studies.
InUnio. Разработка нового оборудования или реагентики
Development of new equipment or reagents
  1. Unique development
    • Reagents or equipment for laboratory diagnostics, data interpretation algorithm.
  2. Cloud white-label software solution
    • Reception, organization and storage of data.
    • Data interpretation, incl. using external data sources, generating conclusions or reports, sending data to external systems.
    • Organization of the process of working with data in the laboratory.
    • Integration of the results of the equipment operation or the results of the interpretation of reagents into existing laboratory / medical information systems through a single data broker InUnio.
InUnio. Разработки неоантигенной вакцины
Development of a neoantigenic vaccine
  1. he doctor conducts the initial diagnosis.
    • Selects protocols for differential diagnosis.
    • He chooses where he can conduct research, determines the list of companies (taking into account the load, price, etc.) that have the necessary resources to conduct research.
    • Receives data.
    • The council determines the diagnosis and treatment protocol.
    • The list of candidate peptides for synthesis is determined.
    • Synthesis of peptides.
    • Creation of a vaccine.
  2. Introduction of the vaccine.
  3. Results monitoring.

For whom and how?

Patients and doctors

Learn about advanced methods of treatment and prevention of diseases, take part in their testing and testing.

Ways to use:
  • Providing stabilized education biomaterial and healthy tissue.
  • Choice of the operator of the neoantigenic protocol (if there is a decision of the council and the ethics committee), transfer of the biomaterial.
  • Selection of an adjuvant, injection of the synthesized drug.
  • Implementation of performance monitoring.
Contact us
InUnio. Patients and doctors
InUnio. Individual researchers, biotechnology startups, pharmaceutical companies

Individual researchers, biotechnology startups, pharmaceutical companies

Increase speed and quality while reducing cost and time of R&D.

Ways to use:
  • Search and interaction with service providers, including scarce equipment.
  • New interpretations of existing data by giving scientists access to already accumulated data.
  • Use of standard solutions.
  • Search and select candidates for clinical trials or access the necessary data in the database.
  • Public profile management.
  • Publication of announcements and protocols.
Contact us

Resource centers and laboratories

Increase the utilization of equipment and personnel, including through international cooperation.

Ways to use:
  • Placement of the range of equipment and personnel available for order, Informing about the availability of capacities.
  • Receipt and execution of applications and information on the collection of proposals.
  • Public profile management.
Contact us
InUnio. Resource centers and laboratories
InUnio. Operators of the neoantigenic protocol

Operators of the neoantigenic protocol

  • Carrying out RNA sequencing of biomaterial in one of the resource centers or independently.
  • Determination of candidate proteins, identification of membrane proteins among them with the involvement of bioinformaticians and data processing centers.
  • Verification of the actual presence of candidate proteins using mass spectrometry at one of the resource centers or by yourself.
  • Detection and scoring of antigens in altered regions of confirmed proteins with the involvement of bioinformaticians.
  • Carrying out peptide synthesis in one of the resource centers or independently.
  • Direction of the synthesized drug to a medical institution.
Contact us

Bioinformaticians and IT companies

Get access to orders and instruments (data brokers, storage and data processing algorithms) in a high potential for income increase area.

Ways to use:
  • Receiving requests for the development of instruments and publication of the developed instruments and algorithms.
  • Use of existing instruments, data and storage systems and existing counterparties.
Contact us
InUnio. Bioinformaticians and IT companies
InUnio. Investors

Investors

Identify areas with high revenue potential, as well as promising means and methods for commercialization.

Contact us

Please contact us for more information

Leave a message